Health and Fitness Health and Fitness
Tue, May 11, 2010
[ 11:43 PM ] - Market Wire
KCI nomeia Ron Silverman m©dico-chefe
[ 11:42 PM ] - Market Wire
KCI beruft Ron Silverman (Arzt, FACS) zum Chief Medical Officer
[ 11:00 PM ] - Market Wire
BrainStorm To Present At World Stem Cells and Regenerative Medicine Congress
[ 10:15 PM ] - Market Wire
ING posts 1Q underlying net profit of EUR 1,018 million
[ 05:05 PM ] - Market Wire
KCI nombra director m©dico al Dr. Ron Silverman (de FACS)
[ 04:54 PM ] - Market Wire
KCI nomina il Dottor Ron Silverman, membro del Co .. americano dei chirurghi (FACS), Direttore medico
[ 04:26 PM ] - Market Wire
Constellation Acquires eFit Financial
[ 04:00 PM ] - Market Wire
Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update
[ 02:38 PM ] - Market Wire
Akela announces overruling and final judgement in Lermer v. Akela
[ 02:34 PM ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against NBTY, Inc.
[ 02:30 PM ] - Market Wire
St. Jude Medical Announces Japanese Approval of L .. that Continuously Monitors Electrical Changes th
[ 02:12 PM ] - Market Wire
Cardiome Reports First Quarter Results
[ 02:00 PM ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Pfizer Inc.
[ 02:00 PM ] - Market Wire
Medtronic, Inc., Haemonetics Corporation, Boston .. ude Medical Inc. and Becton, Dickinson and Compan
[ 02:00 PM ] - Market Wire
Response Genetics, Inc. to Release First Quarter 2010 Financial Results
[ 01:57 PM ] - Market Wire
Cytori to Webcast Corporate Presentation at the M .. Capital Group Investor Conference on May 12, 2010
[ 01:08 PM ] - Market Wire
Exelixis Announces First Quarter 2010 Financial Results
[ 01:05 PM ] - Market Wire
HearUSA Reports First Quarter 2010 Results
[ 01:05 PM ] - Market Wire
Curis to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference
[ 01:05 PM ] - Market Wire
Somaxon Pharmaceuticals Reports First Quarter 2010 Financial Results
[ 01:01 PM ] - Market Wire
Given Imaging Reports First Quarter 2010 Results
[ 01:00 PM ] - Market Wire
Cytokinetics to Present Non-Clinical Data From It .. y Program at the American Thoracic Society's 2010
[ 12:00 PM ] - Market Wire
Hansen Medical Highlights Remote Navigation Capabilities and Clinical Value at Heart Rhythm 2010
[ 11:46 AM ] - Market Wire
How Did More Than 90,000 People Get Health Benefits Advice from the Same Person? Just Ask David
[ 09:45 AM ] - Market Wire
AVANIR Pharmaceuticals Announces Closing of Common Stock Offering
[ 09:32 AM ] - Market Wire
St. Jude Medical introduceert de eerste Europese quadripolaire pacemaker
[ 09:31 AM ] - Market Wire
St. Jude Medical anuncia el lanzamiento europeo d .. mer sistema de estimulacin cuadripolar del sector
[ 09:23 AM ] - Market Wire
Advanced Plant Pharmaceuticals, Inc. to Change Co .. Energy Holdings, Inc. to Reflect Focus on Algae B
[ 09:13 AM ] - Market Wire
Brower Piven Announces an Investigation of the Ac .. s Corporation of America by U.S. Renal Care, Inc.
[ 08:58 AM ] - Market Wire
Teva to Present at the Bank of America Merrill Lynch Health Care Conference

Teva to Present at the Bank of America Merrill Lynch Health Care Conference


Published on 2010-05-11 09:11:31 - Market Wire
  Print publication without navigation


JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Bank of America Merrill Lynch Health Care Conference with Shlomo Yanai, President & Chief Executive Officer, Teva Pharmaceutical Industries Ltd., presenting on Thursday, May 13, 2010 in New York.

What:

 Teva Presentation at the Bank of America Merrill Lynch Annual Health Care Conference

Who:

 Shlomo Yanai, President & Chief Executive Officer, Teva Pharmaceutical Industries Ltd.

When:

 Thursday, May 13, 2010 at 10:40 AM (ET)

Where:

[ https://www.veracast.com/webcasts/bas/healthcare2010/id11345780.cfm ] or
[ http://www.tevapharm.com/financial/ ]

How:

 Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.

Contributing Sources